Pay in 4 interest-free payments of $5.20 Learn more
Ships within 48 hours · Estimated delivery Oct 19 - Oct 24
Purity exceeds 99%, guaranteed
Phase I evaluation of intravenous ascorbic acid in combination with gemcitabine and erlotinib in patients with metastatic pancreatic cancer
Methods Protocol and registration This systematic review and meta-analysis was conducted according to the preferred reporting items for systematic reviews and meta-analyses (PRISMA) guidelines [20]
Most providers complete the course in approximately 3 hours
Plasma non-esterified fatty acid (NEFA) levels were measured using Lab Assay NEFA (FUJIFILM Wako Laboratory Chemicals)
US$ 27.35
US$ 26.75
US$ 20.28
US$ 23.72
